Literature DB >> 34345267

Optimization of a GF-AAS method for lead testing in blood and urine: A useful tool in acute abdominal pain management in emergency.

Mihail Silviu Tudosie1,2, Genica Caragea3, Dragos Marian Popescu4, Oana Avram1,2, Dragos Serban1,5, Catalin Gabriel Smarandache1,5, Corneliu Tudor5, Cristinel Dumitru Badiu1,6, Bogdan Socea1,7, Alexandru Dan Sabau8, Meda Comandasu5, Radu Spataru1,9, Daniel Ovidiu Costea10,11, Ciprian Tanasescu8, Ana Maria Dascalu1,12.   

Abstract

Suspicion of lead poisoning is confirmed by its concentration in blood and protoporphyrin red blood cells. At low concentrations, lead influences the synthesis of the heme in the sense of lowering it. Acute and chronic lead intoxication is extremely polymorphic in regards to its clinical manifestations, with digestive, hematological, cardiovascular, renal hepatic and neurological features. The aim of the study was to evaluate the presence of lead in human whole blood and urine harvested before and during chelation treatment in the case of lead poisoning. An atomic absorption spectroscopic method for the analysis of lead was developed using graphite furnace atomic absorption spectrophotometer (GF-AAS), Varian Spectra AA-880 with a hollow cathode lead lamp and a deuterium lamp for background correction, coupled to a GTA-100 atomizer and a programmable sample dispenser. Standard calibration solutions were used for the range 10-100 µg/l. The linearity range was 10.0 to 100.0 µg/l with the correlation coefficient of 0.999. We established that the method can be applied for the determination of lead in whole blood and urine, and the results obtained are useful for monitoring chelation therapy in cases of acute lead poisoning, a neglected cause of abdominal colic pain in an emergency situation.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  GF-AAS; acute abdominal pain; biological samples; lead toxicity; saturnine colic

Year:  2021        PMID: 34345267      PMCID: PMC8311247          DOI: 10.3892/etm.2021.10417

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  31 in total

1.  Lead accumulation as possible risk factor for primary open-angle glaucoma.

Authors:  Kenya Yuki; Murat Dogru; Yutaka Imamura; Itaru Kimura; Yuichiro Ohtake; Kazuo Tsubota
Journal:  Biol Trace Elem Res       Date:  2009-12       Impact factor: 3.738

2.  NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.

Authors:  Adina Elena Stanciu; Marcel Marian Stanciu; Radu Gabriel Vatasescu
Journal:  Cytokine       Date:  2018-08-08       Impact factor: 3.861

3.  California adults with elevated blood lead levels, 1987 through 1990.

Authors:  N Maizlish; L Rudolph
Journal:  Am J Public Health       Date:  1993-03       Impact factor: 9.308

Review 4.  Lead toxicity and chelation therapy.

Authors:  Rebeca C Gracia; Wayne R Snodgrass
Journal:  Am J Health Syst Pharm       Date:  2007-01-01       Impact factor: 2.637

Review 5.  Advances in metal-induced oxidative stress and human disease.

Authors:  Klaudia Jomova; Marian Valko
Journal:  Toxicology       Date:  2011-03-23       Impact factor: 4.221

6.  Evaluation of activity of erythrocyte pyrimidine 5'-nucleotidase (P5N) in lead exposed workers: with focus on the effect on hemoglobin.

Authors:  Yangho Kim; Cheol-In Yoo; Choong Ryeol Lee; Ji Ho Lee; Hun Lee; Sung-Ryul Kim; Seoung-Hoon Chang; Won-Jin Lee; Cheon-Hyun Hwang; Young Hwan Lee
Journal:  Ind Health       Date:  2002-01       Impact factor: 2.179

7.  Application of Zeeman graphite furnace atomic absorption spectrometry with high-frequency modulation polarization for the direct determination of aluminum, beryllium, cadmium, chromium, mercury, manganese, nickel, lead, and thallium in human blood.

Authors:  Natalya B Ivanenko; Nikolay D Solovyev; Anatoly A Ivanenko; Alexander A Ganeev
Journal:  Arch Environ Contam Toxicol       Date:  2012-08-07       Impact factor: 2.804

8.  Blood erythrocyte concentrations of cadmium and lead and the risk of B-cell non-Hodgkin's lymphoma and multiple myeloma: a nested case-control study.

Authors:  Rachel S Kelly; Thomas Lundh; Miquel Porta; Ingvar A Bergdahl; Domenico Palli; Ann-Sofie Johansson; Maria Botsivali; Paolo Vineis; Roel Vermeulen; Soterios A Kyrtopoulos; Marc Chadeau-Hyam
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

Review 9.  Lead toxicity: a review.

Authors:  Ab Latif Wani; Anjum Ara; Jawed Ahmad Usmani
Journal:  Interdiscip Toxicol       Date:  2015-06

10.  Lead Exposure in Low and Middle-Income Countries: Perspectives and Lessons on Patterns, Injustices, Economics, and Politics.

Authors:  Katarzyna Kordas; Julia Ravenscroft; Ying Cao; Elena V McLean
Journal:  Int J Environ Res Public Health       Date:  2018-10-24       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.